7Baggers
 okyo pharma ceo to present at bio-europe conference in vienna  Investing.com Australia Thu, 30 Oct 2025 03:51:59 GMT
 OKYO Pharma to present positive Phase 2 Data for urcosimod at BIO-Europe 2025  Proactive financial news Wed, 29 Oct 2025 13:29:00 GMT
 OKYO Pharma to Present at BIO-Europe 2025 in Vienna  Yahoo Finance Wed, 29 Oct 2025 07:00:00 GMT
 OKYO Pharma CEO to present at BIO-Europe conference in Vienna  Investing.com Wed, 29 Oct 2025 07:00:00 GMT
 published on: 2025-10-27 17:32:57  newser.com Mon, 27 Oct 2025 22:32:57 GMT

OKYO Pharma
(NASDAQ:OKYO) 

OKYO stock logo

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-...

Founded: 2007
IPO Price: $4 (May 17, 2022)
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends